ESC Heart Failure 2022

Distinct pathophysiological pathways in women and men with heart failure
Distinct pathophysiological pathways in women and men with heart failure
ESC Heart Failure 2022
Distinct pathophysiological pathways in women and men with heart failure
- Alice Ravera, MD
$Phenotyping HF with a supranormal ejection fraction$ $Phenotyping HF with a supranormal ejection fraction$
Phenotyping HF with a supranormal ejection fraction
Phenotyping HF with a supranormal ejection fraction
ESC Heart Failure 2022
Phenotyping HF with a supranormal ejection fraction
- Bart van Essen, MD
An increase in galectin-3 identifies males at risk of new-onset HF and new-onset cancer
An increase in galectin-3 identifies males at risk of new-onset HF and new-onset cancer
ESC Heart Failure 2022
An increase in galectin-3 identifies males at risk of new-onset HF and new-onset cancer
- Freek van den Berg, MD
Ciculating ketonse bodies in acute HF treated with SGLT2i
Ciculating ketonse bodies in acute HF treated with SGLT2i
ESC Heart Failure 2022
Ciculating ketonse bodies in acute HF treated with SGLT2i
- Suzanne Voorrips, MD
Genetic penetrance in cardiomyopathy
Genetic penetrance in cardiomyopathy
ESC Heart Failure 2022
Genetic penetrance in cardiomyopathy
- Remco de Brouwer, MD